| 摘要 |
Disclosed is a use of a protein free, peptide free, composition comprising cholanoic acid or cholanoic acid salt and a phospholipid in the manufacture of a medicament for treating or preventing a condition caused by Gram-positive bacteria, selected from the group consisting of: sepsis, septic shock, systemic inflammatory response syndrome (SIRS), SIRS with organ dysfunction or failure, organ failure, and organ dysfunction, in a subject in need thereof, wherein the medicament is formulated for intravenous administration. Additionally the composition may further comprise a neutral lipid.
|
